arrow
B

Birgit C. Schultes

vita-salute san raffaele university
H指数:22
被引数:2,024

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PRECLINICAL DEVELOPMENT OF KYV-201, AN INVESTIGATIONAL ALLOGENEIC ANTI-CD19 CAR T CELL FORTHE TREATMENT OFAUTOIMMUNE DISEASE

KYV-201的临床前开发,KYV-201是一种用于治疗自身免疫性疾病的同种异体抗CD19 CAR T细胞。

2024-06-011
PRE
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells

上皮性卵巢癌被活化的效应T细胞浸润,这些T细胞共表达CD39,PD-1,TIM-3,CD137并与癌细胞和髓样细胞相互作用

2023-10-043
OAAI
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function

基于CRISPR的基因破坏和整合高亲和力的WT1-specific T细胞受体可改善抗肿瘤T细胞功能

2022-02-0928
OA
In vivo model development for immune cell-based therapeutics
2020-08-150
PRE
Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors
2016-11-1662
PREAI
Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity
2015-03-02199
OAAI